Epidemiology and burden of focal segmental glomerulosclerosis among United States Veterans: An analysis of Veteran’s Affairs data
Among US veterans, FSGS is associated with considerable clinical and economic burdens. Better treatments for FSGS are needed to slow kidney disease progression, improve patient outcomes, and reduce the burden.
Authors
- Lizheng Shi (ORCID: https://orcid.org/0000-0002-7827-6766)
- Yilu Lin (ORCID: https://orcid.org/0000-0001-7040-4287)
- Mark Bensink (ORCID: https://orcid.org/0000-0002-5940-7898)
- Zheng‐Yi Zhou (ORCID: https://orcid.org/0000-0001-9014-8479)
- Sherry Shi
- Deborah Goldschmidt
Institutions
- Tulane University (US)
- Therapeutics Clinical Research (US)
- Southeast Louisiana Veterans Health Care System (US)
- Analysis Group (United States) (US)
Publication Details
- Journal
- PLoS ONE
- Published
- 2024-12-13
- DOI
- https://doi.org/10.1371/journal.pone.0315302
- Citations
- 3
- Primary Topic
- Renal Diseases and Glomerulopathies
- Type
- article
- Field-Weighted Citation Impact
- 1.02